Jun Wang

2004-2006 Chemistry National University of Singapore, Singapore, Singapore 
"Jun Wang"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wu F, Wang G, Wang J, et al. (2020) Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer. Plos One. 15: e0234310
Wang J, Zhang M, Xu Y, et al. (2020) A rare case of inflammation after total hip arthroplasty due to a malpositioned prosthesis: A case report. Medicine. 99: e20468
Wang D, Zhang KF, Du G, et al. (2020) Berberine enhances the radiosensitivity of osteosarcoma by targeting Rad51 and epithelial-mesenchymal transition. Journal of Cancer Research and Therapeutics. 16: 215-221
Huang Y, Li Y, Lou A, et al. (2020) Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS. Clinical Science (London, England : 1979)
Wang G, Chen M, Wang J, et al. (2020) Reinforced Topological Nano-assemblies: 2D Hexagon-Fused Wheel to 3D Prismatic Metallo-lamellar Structure with Molecular Weight of 119K Daltons. Journal of the American Chemical Society
Guo YF, Duan JJ, Wang J, et al. (2020) Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates -amplified neuroblastoma growth. Science Translational Medicine. 12
Yin Y, Wang J, Yang M, et al. (2020) Penetration of the blood-brain barrier and the anti-tumour effect of a novel PLGA-lysoGM1/DOX micelle drug delivery system. Nanoscale
Wang A, Cui C, Fan Y, et al. (2019) Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Critical Care (London, England). 23: 428
Li N, Huang HY, Wu DW, et al. (2019) Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review. The Lancet. Oncology. 20: e619-e626
Liu J, Liu Y, Liu Y, et al. (2019) Anticancer Action of Psilostachyin-A in 5-Fluorouracil-Resistant Human Liver Carcinoma are Mediated Through Autophagy Induction, G2/M Phase Cell Cycle Arrest and Inhibiting Extracellular-Signal-Regulated Kinase/Mitogen Activated Protein Kinase (ERK/MAPK) Signaling Pathway. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 25: 6711-6718
See more...